GRP
PPBT

Global Retirement Partners’s Purple Biotech PPBT Stock Holding History

Global Retirement Partners’s Portfolio PPBT Stock Details PPBT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q4 		$11 Hold
2
– – ﹤0.01% 4212
2025
Q3 		$9 Hold
2
– – ﹤0.01% 3852
2025
Q2 		$38 Buy
+2
New +$49 ﹤0.01% 3765
2024
Q4 		$75 Hold
2
– – ﹤0.01% 3560
2024
Q3 		$89 Hold
2
– – ﹤0.01% 3414
2024
Q2 		$137 Hold
2
– – ﹤0.01% 3445
2024
Q1 		$225 Hold
2
– – ﹤0.01% 3247
2023
Q4 		$224 Hold
2
– – ﹤0.01% 3213
2023
Q3 		$333 Hold
2
– – ﹤0.01% 3046
2023
Q2 		$469 Buy
+2
New +$718 ﹤0.01% 2965

Other funds holding PPBT

Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $124B AUM 33.93% 1-Year Est. Return
SP
SmartHarvest Portfolios Poulsbo, Washington $240M AUM
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
BNP Paribas Financial Markets
BNP Paribas Financial Markets Paris, France $206B AUM 31.61% 1-Year Est. Return
Two Sigma Advisers
Two Sigma Advisers New York $51.4B AUM 31.07% 1-Year Est. Return
Simplex Trading
Simplex Trading Chicago, Illinois $149B AUM 62.07% 1-Year Est. Return
RhumbLine Advisers
RhumbLine Advisers Boston, Massachusetts $117B AUM 29.66% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

Global Retirement Partners's PPBT Position: Q4 2025 in Review

Global Retirement Partners held its Purple Biotech (PPBT) position steady in Q4 2025 at 2 shares worth $11. The position accounts for ﹤0.01% of the portfolio, ranked #4212.

Global Retirement Partners first reported a position in PPBT in Q2 2023 and has held it in 10 quarters since. The position peaked at $469 in Q2 2023. 19 funds tracked by Wall St. Rank hold PPBT as of Q4 2025.

  • Global Retirement Partners held 2 shares of Purple Biotech worth $11 as of Q4 2025.
  • Global Retirement Partners left its Purple Biotech share count unchanged in Q4 2025.
  • Purple Biotech made up ﹤0.01% of Global Retirement Partners's portfolio in Q4 2025, its #4212 holding.
  • Global Retirement Partners first reported a position in Purple Biotech in Q2 2023 and has held it in 10 quarters since.
  • Global Retirement Partners's Purple Biotech position peaked at $469 in Q2 2023.
  • 19 funds tracked by Wall St. Rank held Purple Biotech as of Q4 2025.

Based on Global Retirement Partners's 13F filing for Q4 2025, filed 6 Feb 2026.